Lifescience Global

Journal of Cancer Research Updates - First Issue launched

Cancer-Research-Updates headerAugust 28, 2012 : Lifescience Global launches the first issue of the Journal of Cancer Research Updates . The objective of this journal is to provide a broad coverage of information about cancer research updates from the entire spectrum of basic, translational, and clinical investigations. The journal also aims to highlight the recent advances of cancer research to better understand, treat, and ultimately eradicate cancer.The journal is edited by Prof. Zhe-Sheng Chen of  St. John's University, New York, USA.  To view the first issue please click here

Journal of Cancer Research Updates focuses on publishing novel and significant studies that may have impact on basic and clinical research, prevention and treatment of cancer. The journal accepts research articles, review articles, case reports, editorials, and letters to the editor. Subject categories include:

ABC Transporters and Cancer Chemotherapy
Anti-cancer Drug Discovery and Delivery
Immunology and Cancer
Carcinogenesis
Cell Biology and Molecular Biology in Cancer
Clinical Cancer Research
Epidemiology and Prevention of Cancer
Genetics, Genomics, and Proteomics and Cancer
Inflammation and Cancer
Metabolism and Cancer
Stem Cell and Cancer
Developmental Biology and Cancer
Pathology and Cancer
Biochemistry and Cancer
Pharmacology and Cancer
Pharmaceutics and Cancer
Microbiology and Cancer
Radiology and Cancer

The first issue of the journal carries the below articles:

 

Primary Non-Hodgkin's Lymphoma of the Uterine Cervix: Report of Three Cases with Immunohistochemical Study
Anupam Sarma, Debabrata Barmon, J.D. Sharma, Amal Chandra Kataki, Chidananda Bhuyan
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.01

 

Extramedullary Plasmacytoma of the Lung – Rather a Disseminated than a Localized Disease? – A Case Report of a Primary Pulmonary Plasmacytoma Showing Distinct Signs of Systemic Spread
Lisa Billecke, Eva Maria Murga Penas, Jozef Zustin, Thorsten Derlin, Carsten Bokemeyer and Georgia Schilling
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.02

 

Topical Treatment of Skin Squamous Cell Carcinoma with Potassium Dobesilate Cream
Pedro Cuevas, Javier Angulo, Adrián Cuevas-Bourdier and Guillermo Giménez-Gallego
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.03

 

Moving EGFR Targeted Therapy into the Induction Phase of the Management of Squamous Cell Carcinoma of the Head and Neck
Belisario A. Arango, Bertha E. Sanchez, Matthew C. Abramowitz and Edgardo S. Santos
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.04

 

Does Tumour Biological Behaviour Influence Prognosis More than Diagnostic Delay in Oral Cancer?
Juan Manuel Seoane-Romero, Pablo Ignacio Varela-Centelles, Pedro Diz-Dios, Isabel Ramos-Barbosa, Javier Fernández Feijoo and Juan Seoane
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.05

 

Brain Tumor Stem Cells and Immunotherapy
Isako Saga and Masahiro Toda
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.06

 

Collision Primary Tumor of the Endometrium: Large Cell Neuroendocrine Carcinoma and Endometrioid Adenocarcinoma
Wyatt Unger, Qian Tang, Danielle Summers and Wenxin Zheng
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.07

 

Open AccessLow Leukocyte MGMT Accompanies Temozolomide-Induced Myelotoxicity in
Brain Tumor Patients

Julia E. Stokes, Michael S. Bobola, Marc C. Chamberlain and John R. Silber
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.08

 

Open AccessPAX3-FKHR Regulates the Expression of Pleiotrophin to Mediate Motility in
Alveolar Rhabdomyosarcoma Cells

Lingling Liu and Taosheng Chen
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.09

 

Open AccessTranscriptional Modulation of the ERK1/2 MAPK and NF-kB Pathways in
Human Urothelial Cells After Trivalent Arsenical Exposure: Implications
for Urinary Bladder Cancer

Kathryn A. Bailey, Kathleen Wallace, Lisa Smeester, Sheau-Fung Thai, Douglas C. Wolf, Stephen W. Edwards and Rebecca C. Fry

DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.10

 

Open AccessTissue-Engineered “Metastases”: Treatment of Hepatic Colon Tumors with
a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist

Guanghui Yang, Honglu Zhang and Glenn D. Prestwich
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.11

 

TAT-Mediated Delivery of p27 in Tumor Cell Lines as a Potential Therapeutic Peptide
Ana-Matea Mikecin and Mira Grdisa
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.12

 

Mobile Phone Based Healthcare Platform for Assisting Lung Cancer Prevention
Jun Yang, Bowei Chen and Jing Liu
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.13

 

Present and Emerging Targeted Therapy for Metastatic Breast Cancer
Vito Lorusso, Ilaria Marech, Marianna Giampaglia, Antonio Gnoni, Andrea Tinelli and Vincenzo Emanuele Chiuri
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.14

 

Open AccessEGFR Tyrosine Kinase Inhibitors Prolong Overall Survival in EGFR
Mutated Non-Small-Cell
Lung Cancer Patients with Postsurgical Recurrence

Kenichi Suda, Simon Ito, Hiroshi Mizuuchi, Yoshihiko Maehara, Yasushi Yatabe and Tetsuya Mitsudomi
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.15

 

Open AccessTreatment of Chemotherapy – Induced Peripheral Neuropathy:
The Physicians Need Guidelines,
the Patients Need Help

 

Krzysztof Brzeziński

 

DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.16

 

High-Expression of PTEN and an Absence of PCNA in Osteoclast-Like Multinucleated Giant Cells of
Giant Cell Tumors in Bone

 

Chao Lou, Rong Qiang, Hongmin Yan and Jie Li

 

DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.17

 

Biological Efficacy of a Dendritic Cell-Based Vaccine in a Patient with Metastatic Colorectal Cancer
Mario M. Soldevilla, Susana Inogés, Ascensión López-Díaz de Cerio, Fernando Pastor, Helena Villanueva and Maurizio Bendandi

DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.18

 

Strategies of Targeting Tumors and Cancers
Rajesh K. Saini, Raje Chouhan, Laxmi P. Bagri and A.K. Bajpai

DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.19

 

 

 

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedIn

OUR STRENGTHS

♦  Worldwide readership
♦  High quality content
♦  Maximum visibility
♦  Efficient publishing
♦  Optional Open Access

Publish your Research

Survey

As an author what type of publishing model you prefer?

780
Open Access
493
Optional Open Access
338
Subscription based
5 Votes left